UK Offers Under-30s Alternative to Oxford-AstraZeneca Shot
Click the image below to enlarge the infographic.
- Under-30s in the UK are to be offered an alternative COVID-19 vaccine to the AstraZeneca jab due to evidence of rare blood clots in some recipients
- The recomemndation comes after a review by the UK drugs regulator found that by the end of March, 79 people had suffered rare blood clots following vaccination, 19 of whom had died
- The regulator said although this was not proof that the jab caused the clots, but it said the link was getting stronger
- The UK's Medicines and Healthcare products Regulatory Agency (MHRA) also found that the recorded cases occured after the first dose
- The people that died were aged 18 and 79, with three of them aged under 30
- Meanwhile, the EU's medicines regulator has suggested that rare blood clots should be listed as a rare side effect of the AstraZeneca vaccine, while the World Health Organization said the link between the vaccine and blood clots was "plausible"